Evidence map›Paper›PMID 25400913›Full record

ArticleImmunity, inflammation and disease2013

Optimized fluorescent labeling to identify memory B cells specific for Neisseria meningitidis serogroup B vaccine antigens ex vivo.

Nitya Nair, Ludovico Buti, Elisa Faenzi, Francesca Buricchi, Sandra Nuti, Chiara Sammicheli, Simona Tavarini, Maximilian Wl Popp, Hidde Ploegh, Francesco Berti and 7 more

Open access · goldAbstract read
In one paragraph

Article in Immunity, inflammation and disease, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 2 countries.

Nitya NairNovartis Vaccines & Diagnostics Siena, Italy.
Ludovico ButiNovartis Vaccines & Diagnostics Siena, Italy ; Whitehead Institute for Biomedical Research Cambridge, Massachusetts.
Elisa FaenziNovartis Vaccines & Diagnostics Siena, Italy.
Francesca BuricchiNovartis Vaccines & Diagnostics Siena, Italy.
Sandra NutiNovartis Vaccines & Diagnostics Siena, Italy.
Chiara SammicheliNovartis Vaccines & Diagnostics Siena, Italy.
Simona TavariniNovartis Vaccines & Diagnostics Siena, Italy.
Maximilian Wl PoppWhitehead Institute for Biomedical Research Cambridge, Massachusetts ; University of Rochester, School of Medicine & Dentistry Rochester, New York ; Department of Biology, Massachusetts Institute of Technology Cambridge, Massachusetts.
Hidde PloeghWhitehead Institute for Biomedical Research Cambridge, Massachusetts ; Department of Biology, Massachusetts Institute of Technology Cambridge, Massachusetts.
Francesco BertiNovartis Vaccines & Diagnostics Siena, Italy.
Mariagrazia PizzaNovartis Vaccines & Diagnostics Siena, Italy.
Flora CastellinoNovartis Vaccines & Diagnostics Siena, Italy.
Oretta FincoNovartis Vaccines & Diagnostics Siena, Italy.
Rino RappuoliNovartis Vaccines & Diagnostics Siena, Italy.
Giuseppe Del GiudiceNovartis Vaccines & Diagnostics Siena, Italy.
Grazia GalliNovartis Vaccines & Diagnostics Siena, Italy.
Monia BardelliNovartis Vaccines & Diagnostics Siena, Italy.
Newron Pharmaceuticals (Italy) · ITNovartis (Italy) · ITMassachusetts Institute of Technology · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antigen-specific memory B cells generate anamnestic responses and high affinity antibodies upon re-exposure to pathogens. Attempts to isolate rare antigen-specific memory B cells for in-depth functional analysis at the single-cell level have been hindered by the lack of tools with adequate sensitivity. We applied two independent methods of protein labeling to sensitive and specific ex vivo identification of antigen-specific memory B cells by flow cytometry: stringently controlled amine labeling, and sortagging, a novel method whereby a single nucleophilic fluorochrome molecule is added onto an LPETG motif carried by the target protein. We show that sortagged NadA, a major antigen in the meningococcal serogroup B vaccine, identifies NadA-specific memory B cells with high sensitivity and specificity, comparable to NadA amine-labeled under stringent reaction parameters in a mouse model of vaccination. We distinguish NadA-specific switched MBC induced by vaccination from the background signal contributed by splenic transitional and marginal zone B cells. In conclusion, we demonstrate that protein structural data coupled with sortag technology allows the development of engineered antigens that are as sensitive and specific as conventional chemically labeled antigens in detecting rare MBC, and minimize the possibility of disrupting conformational B cell epitopes.

Indexed as

Antigen-specific memory B cellsflow cytometryNeisseria meningitidis MenBsortaggingvaccination

Identifiers

PMID25400913
PMCPMC4217542
OpenAlexW2154614658

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.